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Clinics 
Age and sex: 67 years old male patient. 
Organomegaly : no hepatomegaly ; splenomegaly ; no 
enlarged lymph nodes ; no central nervous system 
involvement. 
Previous history: 67 year old man with normal CBC 
until 02.23.1993, when first noted to have monocytosis 
(wbc 6900; mono 17%; Absolute Mono Count (AMC) 
1173/mm3), mild anemia (Hgb 13.4/ nl 13.6-16.7) and 
thrombocytopenia (121,000/nl 150-400,000). 
Otherwise clinically well. No significant other medical 
history. CMML by marrow biopsy 12/2001 (WBC 
15,300; Hg 13.0; plt 65,000; AMC 3060/mm3). Initial 
cytogenetic analysis was normal, 46,XY. No treatment 
for 5 years because of stable counts and no symptoms. 
He presented with fatigue and purpura December 2006 
(see description below)  
Blood 
WBC: 30.5 x 109/l; Hb: 13.5 g/dl; platelets: 17,000 x 
109/l; blasts: 1%. 
Bone marrow: AML, M4; 80% monocytoid blasts. 
Cytopathology classification 
Cytology: M4. 
Immunophenotype: Positive for: CD33, CD13, HLA-
DR, CD64, CD16, CD14, CD56 (partial), MPO, CD45 
Negative for: CD34, CD2, CD3, CD19, CD20, TdT, 
cyto CD3, CD7. 
Rearranged Ig or Tcr: not done. 
Pathology: AML, M4. 
Electron microscopy: not done. 
Precise diagnosis: AML, M4. 
Survival 
Date of diagnosis: 12-2006. 
Treatment: Ara-C/Daunorubicin. 
Complete remission: remission was obtained  
Comments: marrow still recovering as of 02/09/07 w/ 
WBC 1900; ANC 670; Hg 10.0; plt 63,000; Abs Mono 
Count 228. 
Relapse: + 
Phenotype at relapse: normal karyotype 46,XY. The 
patient died shortly after the last cytogenetic analysis 
due to disease relapse. 
Status: Dead 02-2007 
Survival: 2 months 
Karyotype 
Sample: Bone Marrow; Culture time: Overnight and 
24h; Banding: G-banding; 450 band level. 
Results: 46,XY,inv(8)(p11.2q13)[6]/46,XY[14] 
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Partial metaphases and partial karyotypes showing the inv(8)(p11q13) 
 
Comments 
A review of the literature revealed six reports of 
inv(8)(p11q13) associated with AML M4 or M5 all 
involving female patients ages 10 months, 15, 19, 21, 
29, and 56 years old (References 1-6, 8-9). This is the 
first report of inv(8)(p11.2q13) associated with AML 
M4 in a male patient and older than 56 years. The  
inversion causes the fusion of the MOZ gene at 8p11.2 
with TIF2 at 8q13. Deguchi et al described the 
requirement for C2HC nucleosome recognition of 
MOZ and the CBP recruitment activity of TIF2 for 
transformation leading to leukemogenesis. The 
propensity of affected females requires further 
investigation, but may just be a bias in the literature 
(Reference 7). 
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